Properties of Two Enterovirus Antibodies that are Utilized in Diabetes Research. Maccari, G., Genoni, A., Sansonno, S., & Toniolo, A. Scientific Reports, 6(1):24757, April, 2016. Number: 1
Properties of Two Enterovirus Antibodies that are Utilized in Diabetes Research [link]Paper  doi  abstract   bibtex   
Human enteroviruses (EVs) comprise \textgreater100 different types. Research suggests a non-chance association between EV infections and type 1 diabetes. Immunohistochemical studies with the anti-EV antibody 5D-8.1 have shown that the EV capsid antigen is present in pancreatic islet cells of diabetic subjects. When it was noticed that 5D-8.1 may cross-react with human proteins, doubt was casted on the significance of the above histopathologic findings. To address this issue, properties of EV antibodies 5D-8.1 and 9D5 have been investigated using peptide microarrays, peptide substitution scanning, immunofluorescence of EV-infected cells, EV neutralization assays, bioinformatics analysis. Evidence indicates that the two antibodies bind to distinct non-neutralizing linear epitopes in VP1 and are specific for a vast spectrum of EV types (not for other human viruses). However, their epitopes may align with a few human proteins at low expected values. When tested by immunofluorescence, high concentrations of 5D-8.1 yelded faint cytoplasmic staining in uninfected cells. At reduced concentrations, both antibodies produced dotted staining only in the cytoplasm of infected cells and recognized both acute and persistent EV infection. Thus, the two monoclonals represent distinct and independent probes for hunting EVs in tissues of patients with diabetes or other endocrine conditions.
@article{maccari_properties_2016,
	title = {Properties of {Two} {Enterovirus} {Antibodies} that are {Utilized} in {Diabetes} {Research}},
	volume = {6},
	issn = {2045-2322},
	url = {http://www.nature.com/articles/srep24757},
	doi = {10.1038/srep24757},
	abstract = {Human enteroviruses (EVs) comprise {\textgreater}100 different types. Research suggests a non-chance association between EV infections and type 1 diabetes. Immunohistochemical studies with the anti-EV antibody 5D-8.1 have shown that the EV capsid antigen is present in pancreatic islet cells of diabetic subjects. When it was noticed that 5D-8.1 may cross-react with human proteins, doubt was casted on the significance of the above histopathologic findings. To address this issue, properties of EV antibodies 5D-8.1 and 9D5 have been investigated using peptide microarrays, peptide substitution scanning, immunofluorescence of EV-infected cells, EV neutralization assays, bioinformatics analysis. Evidence indicates that the two antibodies bind to distinct non-neutralizing linear epitopes in VP1 and are specific for a vast spectrum of EV types (not for other human viruses). However, their epitopes may align with a few human proteins at low expected values. When tested by immunofluorescence, high concentrations of 5D-8.1 yelded faint cytoplasmic staining in uninfected cells. At reduced concentrations, both antibodies produced dotted staining only in the cytoplasm of infected cells and recognized both acute and persistent EV infection. Thus, the two monoclonals represent distinct and independent probes for hunting EVs in tissues of patients with diabetes or other endocrine conditions.},
	language = {en},
	number = {1},
	urldate = {2019-11-28},
	journal = {Scientific Reports},
	author = {Maccari, Giuseppe and Genoni, Angelo and Sansonno, Silvia and Toniolo, Antonio},
	month = apr,
	year = {2016},
	note = {Number: 1},
	keywords = {Application - Antibody Validation / Epitope Mapping, Application - Biomarker Discovery, Application - Infectious Diseases, Application - Other Disease, Country - Italy, Human, PEPperCHIP - Customized - Linear, PEPperMAP - Epitope Mapping - Linear, PEPperMAP - Substitution Scan, Sample Type - Monoclonal/polyclonal antibody},
	pages = {24757},
}

Downloads: 0